New gambogic acid osmotic pump type controlled release preparation and preparation method thereof
A new technology of gambogic acid and controlled-release preparations, which is applied in pharmaceutical formulations, medical preparations containing active ingredients, drug delivery, etc., can solve the problem that it is difficult to prepare single-chamber primary osmotic pump type controlled-release preparations for poorly soluble drugs, and it is impossible to achieve Industrialized production, industrialized production problems, etc., to achieve stable and effective blood drug concentration, prolong blood drug concentration time, and reduce the number of times of medication
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0055] Experiment 1 Preparation of new gambogic acid osmotic pump
[0056] Preparation process and influencing factors of new gambogic acid osmotic pump tablets
[0057] 1.1 Preparation process
[0058] Tablet core: pass new gambogic acid, PEO-N10, lactose, sodium chloride, L-arginine through 80-mesh sieve, weigh according to the prescription amount, mix by equal addition method, add 95% ethanol solution to make soft material, Granulate with a 20-mesh sieve, dry at 40°C for 6 hours, add an appropriate amount of magnesium stearate and mix well.
[0059] Preparation of coating solution: Weigh the prescribed amount of cellulose acetate and dissolve it in acetone to prepare a certain concentration of cellulose acetate acetone solution, add a certain amount of dibutyl phthalate DBP and PEG4000, and place on a magnetic stirrer Stir without heating until the solution is completely dissolved.
[0060] Tablet compression and coating: install the upper and lower punches, adjust the t...
Embodiment 1
[0199] Tablet core prescription (based on about 200mg per tablet, based on the weight of the controlled-release semipermeable coating film accounting for 2% of the weight of the tablet core, the weight of the tablet core is 196mg, and the weight of the film is 4mg):
[0200] Neogambogic acid 3.92mg; Sodium chloride 49mg; PEO-N10 19.6mg; L-arginine 29mg; Sodium lauryl sulfate 20mg; Lactose 30.48mg; Microcrystalline cellulose 24mg; Magnesium stearate 20mg;
[0201] Prescription of semipermeable film coating solution: 15 mg of cellulose acetate; 10 mg of diethyl phthalate; 30 mg of PEG4000.
[0202] Preparation process: pass the above-mentioned neogambogic acid and auxiliary materials (other auxiliary materials except magnesium stearate) according to the prescription amount through a 100-mesh sieve, mix well, use 95% ethanol solution to make soft materials, and pass through a 24-mesh sieve to granulate , dried at 40°C, passed through a 24-mesh sieve for granulation, added the pre...
Embodiment 2
[0204] Tablet core prescription (based on about 200 mg per tablet, based on the weight of the controlled-release semipermeable coating film accounting for 3% of the weight of the tablet core, the weight of the tablet core is 194 mg, and the weight of the film is 6 mg):
[0205] Neogambogic acid 19.4mg; Polyoxyethylene 67.9mg; PEO-N10 48.5mg; Sodium bicarbonate 20mg; Sodium lauryl sulfate 28.5mg; Lactose 10.1mg; Compressible starch 14mg; Hydrogenated vegetable oil 5mg;
[0206] Prescription of semipermeable film coating solution: acrylic resin 10mg; propylene glycol 25mg; PEG1500 75mg.
[0207] Preparation process: pass new gambogic acid and auxiliary materials (other auxiliary materials except hydrogenated vegetable oil) through a 100-mesh sieve, mix well, use 95% ethanol solution to make soft materials, pass through a 24-mesh sieve to granulate, dry at 35 ° C, and pass through Sieve with a 24-mesh sieve, add the prescribed amount of hydrogenated vegetable oil, mix evenly, pre...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


